|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 33/00 | |
| A61K 33/40 | |||
| A61K 33/20 | |||
| A61P 25/28 | |||
| A61K 9/00 | |||
| A61K 47/02 |
| (11) | Number of the document | 2574342 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12192303.1 |
| Date of filing the European patent application | 2005-01-25 | |
| (97) | Date of publication of the European application | 2013-04-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 541576 P | 2004-02-03 | US |
| (72) |
McGrath, Michael S., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | Chlorite in the treatment of neurodegenerative disease |
| Chlorite in the treatment of neurodegenerative disease |